Tamoxifen-inducible NaV1.8-CreERT2 recombinase activity in nociceptive neurons of dorsal root ganglia

Genesis (United States)

Volumn 44, Issue 8, 2006, Pages 364-371

  Zhao, Jing ^a   Nassar, Mohammed A ^a   Gavazzi, Isabella ^b   Wood, John N ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Behavior; DRG; Nav1.8 CreERT2; Pain and nociception; ROSA26 reporter; Tamoxifen inducible

Indexed keywords

CRE RECOMBINASE; CREERT2 RECOMBINASE; TAMOXIFEN; UNCLASSIFIED DRUG; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; ESTROGEN RECEPTOR; INTEGRASE; SENSORY NEURON SPECIFIC (SNS) SODIUM CHANNEL; SODIUM CHANNEL;

ANIMAL TISSUE; ARTICLE; CELL CULTURE; DNA FLANKING REGION; ENZYME ACTIVITY; GENE DELETION; HETEROZYGOSITY; LOXP SITE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; REPORTER GENE; SENSORY NERVE CELL; SEQUENCE HOMOLOGY; SPINAL GANGLION; ALLELE; ANIMAL; CROSS BREEDING; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HETEROZYGOTE; METABOLISM; NOCICEPTIVE RECEPTOR; TIME; TRANSGENIC MOUSE;

ANIMALIA;

ALLELES; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; CELLS, CULTURED; CROSSES, GENETIC; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; GENES, REPORTER; HETEROZYGOTE; INTEGRASES; MICE; MICE, TRANSGENIC; NEURONS, AFFERENT; NOCICEPTORS; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; SODIUM CHANNELS; TAMOXIFEN; TIME FACTORS;

EID: 33748652687     PISSN: 1526954X     EISSN: 1526968X     Source Type: Journal    
DOI: 10.1002/dvg.20224     Document Type: Article

References (23)

1. Abremski K, Hoess R. 1984. Bacteriophage P1 site-specific recombination. Purification and properties of the Cre recombinase protein. J Biol Chem 259:1509-1514.
2. Akopian AN, Sivilotti L, Wood JN. 1996. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 379:257-262.
3. Battaglia AA, Sehayek K, Grist J, McMahon SB, Gavazzi I. 2003. EphB receptors and ephrin-B ligands regulate spinal sensory connectivity and modulate pain processing. Nat Neurosci 6:339, 340.
4. Djouhri L, Fang X, Okuse K, Wood JN, Berry CM, Lawson SN. 2003. The TTX-resistant sodium channel Nav1.8 (SNS/PN3): Expression and correlation with membrane properties in rat nociceptive primary afferent neurons. J Physiol 550:739-752.
5. Parley FW, Soriano P, Steffen LS, Dymecki SM. 2000. Widespread recombinase expression using FLPeR (flipper) mice. Genesis 28:106-110.
6. Feil R, Wagner J, Metzger D, Chambon P. 1997. Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun 237:752-757.
7. Hayashi S, McMahon AP. 2002. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: A tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol 244:305-318.
8. Indra AK, Warot X, Brocard J, Bornert JM, Xiao JH, Chambon P, Metzger D. 1999. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: Comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res 27:4324-4327.
9. Joyner AL. 2000. Gene targeting. Oxford: Oxford University Press.
10. Le Y, Sauer B. 2001. Conditional gene knockout using Cre recombinase. Mol Biotechnol 17:269-275.
11. Leone DP, Genoud S, Atanasoski S, Grausenburger R, Berger P, Metzger D, Macklin WB, Chambon P, Suter U. 2003. Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells. Mol Cell Neurosci 22:430-440.
12. Mattioni T, Louvion JF, Picard D. 1994. Regulation of protein activities by fusion to steroid binding domains. Methods Cell Biol 43 (Part A):335-352.
13. Metzger D, Chambon P. 2001. Site- and time-specific gene targeting in the mouse. Methods 24:71-80.
14. Miyata Y. 2005. Hsp90 inhibitor geldanamycin and its derivatives as novel cancer chemotherapeutic agents. Curr Pharm Des 11:1131-1138.
15. Nagy A. 2000. Cre recombinase: The universal reagent for genome tailoring. Genesis 26:99-109.
16. Nassar MA, Stirling LC, Forlani G, Baker MD, Matthews EA, Dickenson AH, Wood JN. 2004. Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. Proc Natl Acad Sci USA 101:12706-12711.
17. Picard D. Regulation of protein function through expression of chimaeric proteins. 1994. Curr Opin Biotechnol 5:511-515.
18. Sambrook J, Russell DW. 2001. Molecular cloning. A laborartory manual, 3rd ed. New York: Cold Spring Harbor Laboratory Press.
19. Soriano P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21:70, 71.
20. Stirling LC, Forlani G, Baker MD, Wood JN, Matthews EA, Dickenson AH, Nassar MA. 2005. Nociceptor-specific gene deletion using heterozygous Na(V)1.8-Cre recombinase mice. Pain 113:27-36.
21. Wang H, Sun H, Della PK, Benz RJ, Xu J, Gerhold DL, Holder DJ, Koblan KS. 2002. Chronic neuropathic pain is accompanied by global changes in gene expression and shares pathobiology with neurodegenerative diseases. Neuroscience 114:529-546.
22. Whitesell L, Lindquist SL. 2005. HSP90 and the chaperoning of cancer. Nat Rev Cancer 5:761-772.
23. Wood JN, Akopian AN, Baker M, Ding Y, Geoghegan F, Nassar M, Malik-Hall M, Okuse K, Poon L, Ravenall S, Sukumaran M, Souslova V. 2002. Sodium channels in primary sensory neurons: Relationship to pain states. Novartis Found Symp 241:159-168.